Myre is a medical oncologist with Elmhurst Hematology Oncology Group in Elmhurst, Illinois.
Letter: Declassifying Gleason 6 as a cancer would do more harm than good
"We feel a more appropriate approach would be to retain true Gleason 6 as a cancer of extremely low metastatic potential requiring close follow-up," write Harris et al.
CMS issues reimbursement code for PSMA-PET imaging agent Gozellix
Pearls & Perspectives: Testosterone and the Future of Men’s Health, with John P. Mulhall, MD
Carotuximab plus apalutamide demonstrates safety, tolerability in mCRPC
Study shows favorable outcomes with guideline-based treatment for localized prostate cancer